Connection

Hamidreza Jamaati to Drug Therapy, Combination

Back to Details
This is a "connection" page, showing publications Hamidreza Jamaati has written about Drug Therapy, Combination.
Hamidreza Jamaati
Connection Strength
0.060
Drug Therapy, Combination
  1. Evaluation of adalimumab effects in managing severe cases of COVID-19: A randomized controlled trial. Int Immunopharmacol. 2021 Oct; 99:107961.
    View in: PubMed
    Score: 0.021
  2. Evaluating the effects of Intravenous Immunoglobulin (IVIg) on the management of severe COVID-19 cases: A randomized controlled trial. Int Immunopharmacol. 2021 Jan; 90:107205.
    View in: PubMed
    Score: 0.020
  3. Subcutaneous administration of interferon beta-1a for COVID-19: A non-controlled prospective trial. Int Immunopharmacol. 2020 Aug; 85:106688.
    View in: PubMed
    Score: 0.019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.